Author:
Huang Ping-Wun,Tsai Shih-Chung,Luo Tsai-Yueh,Kao Chia-Hung,Lin Wan-Yu
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference15 articles.
1. Jeong JM, Kim YJ, Lee YS, Ko JI, Son M, Lee DS, et al. Lipiodol solution of a lipophilic agent, 188Re-TDD, for the treatment of liver cancer. Nucl Med Biol. 2001;28:197–204.
2. Wang SJ, Lin WY, Chen MN, Hsieh BT, Shen LH, Tsai ZT, et al. Biodistribution of rhenium-188 lipiodol infused via the hepatic artery of rats with hepatic tumours. Eur J Nucl Med. 1996;23:13–7.
3. Luo TY, Hsieh BT, Wang SJ, Lin WY, Lee TW, Shen LH, et al. Preparation and biodistribution of rhenium-188 ECD/lipiodol in rats following hepatic arterial injection. Nucl Med Biol. 2004;31:671–7.
4. Garin E, Denizot B, Noiret N, Lepareur N, Roux J, Moreau M, et al. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma. Nucl Med Commun. 2004;25:1007–13.
5. Sundram FX, Jeong JM, Zanzonico P, Bernal P. Trans-arterial rhenium-188 Lipiodol in the treatment of inoperable hepatocellular carcinoma. An IAEA-sponsored multi-centre phase I study. World J Nucl Med. 2002;1:5–11.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献